Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease - Secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT)

Circulation Journal

Volumn 66, Issue 12, 2002, Pages 1096-1100

  Mabuchi, Hiroshi ^a   Kita, Toru ^b   Matsuzaki, Masunori ^c   Matsuzawa, Yuji ^d   Nakaya, Noriaki ^e   Oikawa, Shinichi ^f   Saito, Yasushi ^g   Sasaki, Jun ^h   Shimamoto, Kazuaki ⁱ   Itakura, Hiroshige ^j  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e Fussa Hospital   (Japan)

^f NIPPON MEDICAL SCHOOL   (Japan)

^g CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

ⁱ SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j IBARAKI CHRISTIAN UNIVERSITY   (Japan)

more..

Author keywords

Cholesterol lowering medication; Coronary heart disease; Hyperlipidemia; Longitudinal study; Risk factors; Simvastatin

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; HYPOCHOLESTEROLEMIC AGENT;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DISEASE COURSE; DOSE RESPONSE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; JAPAN; LIPID BLOOD LEVEL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RISK FACTOR; BLOOD; CORONARY ARTERY DISEASE; FOLLOW UP; MIDDLE AGED; OSMOLARITY;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; COHORT STUDIES; CORONARY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; RISK FACTORS; SIMVASTATIN;

EID: 0036896569     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.66.1096     Document Type: Article

References (26)

1. National Cholesterol Education Program. Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994; 89: 1333-1445.
2. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Study. JAMA 1986; 256: 2835- 2838.
3. Stamler J, Wentworth D, Neaton JD. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986; 256: 2823-2828.
4. Keys A, Menotti A, Aravanis C, Blackburn H, Djordevic BS, Buzina R, et al. The Seven Countries Study: 2,289 Deaths in 15 years. Prev Med 1984; 2: 141-154.
5. Pedersen TR, Wilhelmsen L, Faergeman O, Strandberg TE, Thorgeirsson G, Troedsson L, et al. and Scandinavian Simvastatin Survival Study Group: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
6. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996; 335: 1001-1009.
7. Tonkin A, Aylward P, Colquhoun D, Glasziou P, Harris P, Hunt D, et al. and the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) study group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels: The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998: 339: 1349-1357.
8. Sugimoto K, Chikamori T, Kitaoka H, Furuno T, Seo H, Takata J, et al. Efficacy of cholesterol lowering therapy on the prognosis of Japanese patients with coronary heart disease. J Noninvasive Cardiol 1999; 3: 86-90.
9. Todd PA, Goa KL. Simvastatin: A review of its pharmacological properties and therapeutic potential in hypercholesterolemia. Drugs 1990; 40: 584-607.
10. Kodama K, Sasaki H, Shimizu Y. Trend of coronary heart disease and its relationship to risk-factors in a Japanese population: A 26-year follow-up, Hiroshima/Nagasaki study. Jpn Circ J 1990; 54: 414-421.
11. Wakugami K, Iseki K, Kimura Y, Okumura K, Ikemiya Y, Muratani H, et al. Relationship between serum cholesterol and the risk of acute myocardial infarction in a screened cohort in Okinawa, Japan. Jpn Circ J 1998; 62: 7-14.
12. Okayama A, Ueshima H, Marmot MG, Nakamura M, Kita Y, Yamakawa M. Changes in total serum cholesterol and other risk factors for cardiovascular disease in Japan 1980-1989. Int J Epidemiol 1993; 22: 1038-1047.
13. Investigating Committee on Guidelines for Diagnosis and Treatment of Hyperlipidemias. Japan Atherosclerosis Society. Guidelines for diagnosis and treatment of hyperlipidemias in adults. Jpn J Atheroscler 1997; 25: 1-34.
14. Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, et al. and the J-LIT Study Group. Large scale cohort study on the relationship between serum cholesterol concentration and coronary events under low-dose simvastatin therapy in Japanese patients with hypercholesterolemia: Primary Prevention Study of the Japan Lipid Intervention Trial (J-LIT). Circ J 2002; 66 (accepted for publication).
15. Matsuzawa Y, Itakura H, Kita T, Mabuchi H, Matsuzaki M, Nakaya N, et al. and the J-LIT Study Group: Design and baseline characteristics of a cohort study in Japanese patients with hypercholesterolemia: The Japan Lipid Intervention Trial (J-LIT). Curr Ther Res 2000; 61: 219-243.
16. International Statistical Classification of Diseases and Related Health Problems, Vol. 1, 10th Revision. Geneva: World Health Organization, 1992; 471-513.
17. WHO MONICA Project. MONICA Manual, Revised Edn. Geneva: Cardiovascular Disease Unit, WHO, 1990.
18. Cox DR. Regression methods of life tables (with discussion). JR Stat Soc 1972; B34: 187-220.
19. Miwa K, Nakagawa K. Risk factors that discriminate 'high-risk' from 'low-risk' Japanese patients with coronary artery disease. Jpn Circ J 2000; 64: 825-830.
20. Saku K, Zhang B, Liu R, Shirai K, Arakawa K. Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a). Jpn Circ J 1999; 63: 659-665.
21. Jarrett RJ, McCartney P, Keen H. The Bedford survey: Ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 1982; 22: 79-84.
22. Butler WJ, Ostrander LD Jr, Carman WJ, Lamphiear DE. Mortality from coronary heart disease in the Tecumseh study: Long-term effect of diabetes mellitus, glucose tolerance and other risk factors. Am J Epidemiol 1985; 121: 541-547.
23. Borch-Johnsen K, Kreiner S. Proteinuria: Value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. BMJ 1987; 294: 1651-1654.
24. Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick KJ, Asmal AC, et al. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 1987; 59: 750-755.
25. Jarrett RJ, Shipley MJ. Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease: Putative association via common antecedents: Further evidence from the Whitehall Study. Diabetologia 1988; 31: 737-740.
26. Morrish NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H. A prospective study of mortality among middle-aged diabetic patients (the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics). II: Associated risk factors. Diabetologia 1990; 33: 542-548.